Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in EDIT — Editas Medicine, Inc.

CIK 1692234 Seattle, WA
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$485,558
+$137,089 QoQ
Shares Held
149,864
+6.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 216 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. EDIT ranks #153 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in EDIT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $485,558 149,864
2026-03-31 $348,469 141,082
2025-12-31 $195,785 95,506
2025-09-30 $272,630 78,568
2025-06-30 $9,957 4,526
2025-03-31 $11,953 10,305
2024-12-31 $60,586 47,708
2024-09-30 $174,458 51,161
2024-06-30 $269,079 57,619
2024-03-31 $95,257 12,838
2023-12-31 $52,574 5,190
2023-09-30 $8,065 1,034
2023-06-30 $19,644 2,387
2023-03-31 $17,987 2,481
2022-12-31 $127,239 14,345
2022-09-30 $468,766 38,298
2022-06-30 $32,153 2,718
2021-12-31 $467,996 17,627
2021-09-30 $1,455,503 35,431
2021-06-30 $1,235,714 21,817
2021-03-31 $2,001,216 47,648
2020-12-31 $3,977,760 56,736
2020-09-30 $3,123,020 111,298
2020-06-30 $3,377,797 114,192
2020-03-31 $870,614 43,904